DOT1L as a Therapeutic Target: Insights into Epigenetic Regulation and Cancer Treatment
{{output}}
Disruptor of Telomeric Silencing 1-Like (DOT1L) has emerged as a critical epigenetic regulator in cancer, primarily because of its role as the sole histone methyltransferase responsible for histone H3 at lysine 79 methylation. This modification affects transcr... ...
